Predictive Character Analysis of Ganglionic Echography for the Diagnostic of Benin or Malignant Superficial Adenopathy (EGAS)

July 11, 2016 updated by: University Hospital, Brest

Analyse du caractère prédictif de l'échographie Ganglionnaire Pour le Diagnostic de bégninité ou malignité d'Une adénopathie Superficielle

Investigators need to establish a formal diagnostic of superficial adenopathy through complementary investigations to find etiologic diagnostic ( Echography, adenogram).

Echography examination should be a guide to take in charge the adenopathy and to predict presence of malignant (primitive) or benin (reactional) character of adenopathy. The aim of this study is to codify the management of adenopathic patient with a diagnostic in 48 hours after examination. This fast diagnostic helps to prevent unnecessary biopsy, to avoid wasting time in case of a serious pathology.

Study Overview

Status

Unknown

Conditions

Study Type

Observational

Enrollment (Anticipated)

300

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

  • France
      • Brest, France, 29609
        • Recruiting
        • CHRU de Brest
        • Principal Investigator:
          • Gaëlle Guillerm
        • Principal Investigator:
          • Hussam Saad
        • Principal Investigator:
          • Jean-Christophe Ianotto
        • Contact:
        • Principal Investigator:
          • Adrian Temspecul
        • Principal Investigator:
          • Jean-Richard Eveillard
        • Principal Investigator:
          • Florence Dalbies
        • Principal Investigator:
          • Marie-Anne Couturier
      • Brest, France, 29200
        • Not yet recruiting
        • Cabinet Brest
        • Contact:
          • Dominique Nerriec
      • Brest, France, 29200
        • Not yet recruiting
        • Caninet Brest Centre
        • Contact:
          • Pierre Barraine
      • Ergue Gaberic, France, 29500
        • Not yet recruiting
        • Cabinet Ergue Gaberic
        • Contact:
          • Gilles De Chazal
      • Ergue Gaberit, France, 29500
        • Not yet recruiting
        • Cabinet Ergue Gaberic
        • Contact:
          • Stéphane Primault
      • Ergue Gaberit, France, 29500
        • Not yet recruiting
        • Cabinet Ergue Gaberit
        • Contact:
          • Jean-François Velly
      • Lanmeur, France, 29620
        • Not yet recruiting
        • Cabinet Lamneur
        • Contact:
          • Jean-Yves Reste
      • Lanmeur, France, 29620
        • Not yet recruiting
        • Cabinet Lanmeur
        • Contact:
          • Emilie Beck-Robert
      • Le Guilvinec, France, 29730
        • Not yet recruiting
        • Cabinet Le Guilvinec
        • Contact:
          • Dominique Le Bail
      • Le Guilvinec, France, 29730
        • Not yet recruiting
        • Cabine Le Guivinec
        • Contact:
          • Bernard Le Floch
      • Le Relecq Kerhuon, France, 29480
        • Not yet recruiting
        • Cabinet Brest Centre
        • Contact:
          • Benoît Chiron
      • Lesconil, France, 29740
        • Not yet recruiting
        • Cabinet Lesconil
        • Contact:
          • Jean-Jérôme Le Coq
      • Penmarch, France, 29760
        • Not yet recruiting
        • Cabinet Penmarch
        • Contact:
          • Jannick Saliou
      • Plouegat Guerrand, France, 29620
        • Not yet recruiting
        • Cabinet Plouegat Guerrand
        • Contact:
          • Daniel Le Floc'h
      • Quimper, France, 29107
      • Quimper, France, 29000
        • Not yet recruiting
        • Cabinet Quimper
        • Contact:
          • Nikan Mohtadi

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Patient from ambulatory medicine consultation with superficial adenopathy

Description

Inclusion Criteria:

- superficial adenopathy

Exclusion Criteria:

- obvious adenopathy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Parameter of echography
Time Frame: inclusion
The benign or malignant nature of adenopathy (or lymphadenopathy) confirmed by adenogram results +/- lymph node biopsy (as the gold standard)"
inclusion

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

University Hospital, Brest

Investigators

  • Principal Investigator: Christian Berthou, CHRU de Brest

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

May 1, 2016

Primary Completion (Anticipated)

April 1, 2019

Study Completion (Anticipated)

April 1, 2019

Study Registration Dates

First Submitted

January 4, 2016

First Submitted That Met QC Criteria

January 4, 2016

First Posted (Estimate)

January 5, 2016

Study Record Updates

Last Update Posted (Estimate)

July 12, 2016

Last Update Submitted That Met QC Criteria

July 11, 2016

Last Verified

June 1, 2016

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • EGAS - RB 14.077

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Superficial Adenopathy

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Peru

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe